User:Wowbagger2/sandbox
Appearance
Clinical data | |
---|---|
Trade names | Aliqopa (US) |
Other names | BAY 80-6946 |
AHFS/Drugs.com | Aliqopa |
MedlinePlus | a617044 |
License data | |
Routes of administration | intravenous infusion only |
Drug class | PI3-Kinase inhibitor |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 84.2%[1] |
Metabolism | CYP3A4/5 (~90%), CYP1A1 (~10%)[1] |
Elimination half-life | 39.1 hours (range: 14.6 to 82.4)[1] |
Excretion | Feces (64%), Urine (22%); 14% were not recovered |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C23H28N8O4 |
Molar mass | 480.529 g·mol−1 |
3D model (JSmol) | |
|